Portal Diabetes, Inc.

This early-stage study is testing the safety and performance of a new, concentrated insulin formulation. It involves 25 adults with Type 1 Diabetes. Researchers will inject the insulin into the abdomen and carefully monitor how the body absorbs it and controls blood sugar over 12…